Challenge Patients in the US suffering from a particularly rare and debilitating metabolic disease have no approved treatment options available to them. To help support these patients, a US physician had, at one time, managed [...]

Challenge A leading pharmaceutical company wanted to supply its portfolio of treatments for a rare congenital disease into new markets on an unlicensed basis. This required the company to navigate the varied regulatory landscapes across [...]